Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : TBI-166
Catalog No.: PC-20072Not For Human Use, Lab Use Only.
TBI-166 is a potential next-generation antituberculosis riminophenazine with activity against Mycobacterium tuberculosis (0.063 μg/ml).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
TBI-166 is a potential next-generation antituberculosis riminophenazine with activity against Mycobacterium tuberculosis (0.063 μg/ml).
TBI-166 shows MICs against 16 drug-sensitive clinical isolates range from <0.005 to 0.15 μg/ml, lower than those for clofazimine (CFZ) (0.026 to 0.633 μg/ml).
TBI-166 maintained activity against Mycobacterium fortuitum and Mycobacterium scrofulaceum despite having higher MICs.
TBI-166 exhibited activity against M. tuberculosis H37Rv infecting J774A.1 cells with CFU reductions of 0.54, 0.61, and 1.13 log10 at concentrations of 0.0625, 0.25, and 1 μg/ml, respectively.
TBI-166 demonstrated activity at least equivalent to that of CFZ against intracellular M. tuberculosis and in low-dose aerosol infection models of acute and chronic murine tuberculosis.
| M.Wt | 589.62 | |
| Formula | C32H30F3N5O3 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Xu J, et al. Antimicrob Agents Chemother. 2019 Apr 25;63(5):e02155-18.
2. Zhang Y, et al. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e02496-18.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
